scholarly article | Q13442814 |
P50 | author | Naomi Yoshuantari | Q89056793 |
Susanna Hilda Hutajulu | Q89056795 | ||
Johan Kurnianda | Q89056796 | ||
Ahmad Ghozali | Q89056797 | ||
P2093 | author name string | Didik Setyo Heriyanto | |
P2860 | cites work | Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 |
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression | Q24635943 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Cancer statistics, 2007 | Q29547293 | ||
Cancer statistics, 2016 | Q29547383 | ||
Chemokines: a new classification system and their role in immunity | Q29615663 | ||
Optimization of the Isolation and Amplification of RNA From Formalin-fixed, Paraffin-embedded Tissue: The Armed Forces Institute of Pathology Experience and Literature Review | Q33720473 | ||
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma | Q33775283 | ||
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
Effector memory T cells, early metastasis, and survival in colorectal cancer | Q33992461 | ||
CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis | Q34151630 | ||
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion | Q35875566 | ||
Role of chemokines in tumor growth | Q36120825 | ||
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment | Q36306137 | ||
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. | Q36324953 | ||
Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer | Q36667494 | ||
Minimally invasive biomarkers for detection and staging of colorectal cancer | Q36726838 | ||
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. | Q37684176 | ||
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients | Q37685449 | ||
Metastatic colorectal cancer: from improved survival to potential cure | Q37762682 | ||
The expression and role of CXC chemokines in colorectal cancer. | Q37946029 | ||
A review on CXCR4/CXCL12 axis in oncology: no place to hide. | Q38017493 | ||
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial | Q38661133 | ||
Targeting SDF-1 in multiple myeloma tumor microenvironment | Q38666014 | ||
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. | Q39333110 | ||
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy | Q39337489 | ||
Occult anterograde flow is an under-recognized but crucial predictor of early recanalization with intravenous tissue-type plasminogen activator. | Q40258410 | ||
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients | Q40283597 | ||
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation | Q40381071 | ||
CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer | Q41041246 | ||
The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study. | Q41614934 | ||
Chemokine receptor expression by human intestinal epithelial cells | Q41681584 | ||
Will the Stroma-derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer? | Q42592787 | ||
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway | Q44078163 | ||
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer | Q45870196 | ||
Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria | Q47378801 | ||
The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma. | Q50854225 | ||
Response to Letter Regarding Article,"Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies". | Q52986560 | ||
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. | Q53383475 | ||
CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer. | Q54228829 | ||
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. | Q54669043 | ||
Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice | Q71829474 | ||
Differential CXC receptor expression in colorectal carcinomas | Q79719780 | ||
Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer | Q80643044 | ||
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression | Q83187267 | ||
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment | Q84424082 | ||
Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies | Q85075420 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 9613185 | |
P577 | publication date | 2018-05-16 | |
P1433 | published in | Gastroenterology research and practice | Q26853898 |
P1476 | title | Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer | |
P478 | volume | 2018 |
Search more.